insights_auto
Miks on 0QF tõusnud? 2,51%?
Uurige põhjalikumaltchevron_right
0QF:ETR
Moderna Inc
175,42 €
arrow_upward
+2,51%(+4,30) 1 p
29. sept, 17:35:33 GMT +2 · EUR
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 0QF põhistatistika genereerimine…
Ava
173,12 €
Kõrge
184,20 €
Madal
171,00 €
Turu kapit.
81,23 mld
Keskm. maht
43,79 tuh
Maht
25,81 tuh
52 näd kõrgeim
184,20 €
52 näd madalaim
19,37 €
Töötajate arv
5 tuh
Ava
173,12 €
Kõrge
184,20 €
Madal
171,00 €
Turu kapit.
81,23 mld
Keskm. maht
43,79 tuh
Maht
25,81 tuh
52 näd kõrgeim
184,20 €
52 näd madalaim
19,37 €
Töötajate arv
5 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
4 tunni eest
Moderna stock after-hours at EUR 176.87: plus 1.89 percent versus Lang & Schwarz prior close
Investing.com
·
9 tunni eest
Moderna stock hits 52-week high at 202.69 USD
AD HOC NEWS
·
13 tunni eest
Moderna stock trades at EUR 172.26 ahead of melanoma data
The Globe and Mail
·
1 päeva eest
Moderna vs. BioNTech: Which mRNA Cancer Stock Has More Upside?
Profiil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
Teave üksuse Moderna Inc kohta